Gagan Deep Singh, MD | |
836 Round Hill Dr, Merced, CA 95348-8422 | |
(718) 501-4585 | |
Not Available |
Full Name | Gagan Deep Singh |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 21 Years |
Location | 836 Round Hill Dr, Merced, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093074429 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | A142133 (California) | Primary |
Entity Name | Cep America - California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | County Of Santa Clara |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659450955 PECOS PAC ID: 1254244973 Enrollment ID: O20040113000757 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | County Of Santa Clara |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699885079 PECOS PAC ID: 1254244973 Enrollment ID: O20040113000784 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | Woodland Emergency Physicians Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881868164 PECOS PAC ID: 8921176785 Enrollment ID: O20081007000014 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | Golden State Emergency Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770886558 PECOS PAC ID: 4981885951 Enrollment ID: O20110223001018 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | Victory Emergency Physicians Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932402716 PECOS PAC ID: 9133301732 Enrollment ID: O20110302000980 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | County Of Santa Clara |
---|---|
Entity Type | Part B Supplier - Other Medical Care Group |
Entity Identifiers | NPI Number: 1629301346 PECOS PAC ID: 1254244973 Enrollment ID: O20110318000170 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | San Joaquin Emergency Medical Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588960413 PECOS PAC ID: 6305022047 Enrollment ID: O20110516000103 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | Big River Emergency Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033501168 PECOS PAC ID: 2466764303 Enrollment ID: O20150706002430 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Entity Name | Gagan Deep Singh Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184278798 PECOS PAC ID: 4789017385 Enrollment ID: O20191212002588 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Gagan Deep Singh, MD 836 Round Hill Dr, Merced, CA 95348-8422 Ph: (718) 501-4585 | Gagan Deep Singh, MD 836 Round Hill Dr, Merced, CA 95348-8422 Ph: (718) 501-4585 |
News Archive
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.
CRISPR-Cas9 is the go-to technique for knocking out genes in human cell lines to discover what the genes do, but the efficiency with which it disables genes can vary immensely.
A new clinical trial testing a disease-modifying drug for multiple sclerosis will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands.
New York state is drawing up plans for a budget shortfall almost twice as large as the $1.35 billion gap described by Gov. Andrew Cuomo on Tuesday, as the federal government seeks to reduce how much it pays for health care to some of the state's most severely disabled people.
› Verified 4 days ago
Dr. John William Mcneil Ii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Mercy Ave, Merced, CA 95340 Phone: 209-564-5000 | |
Ma Lovely Batasin, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 333 Mercy Ave, Merced, CA 95340 Phone: 209-564-5000 | |
Martin Rossip, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3278 Denver Ave, Ofc, Merced, CA 95348 Phone: 209-725-8000 | |
Dr. Stephen John Backman, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 E 13th St, Merced, CA 95340 Phone: 209-385-7111 Fax: 209-385-7066 | |
James C. Hardy Jr., Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 E 13th St, Merced, CA 95340 Phone: 209-385-7111 Fax: 209-385-7066 | |
Dr. John Thomas Ludlow, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 333 Mercy Ave, Merced, CA 95340 Phone: 209-564-5000 |